Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 911
Publisher
MDPI AG
Online
2019-06-28
DOI
10.3390/cancers11070911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
- (2019) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Wound Healing Fluid Reflects the Inflammatory Nature and Aggressiveness of Breast Tumors
- (2019) Roberto Agresti et al. Cells
- The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
- (2018) Luca Forte et al. BMC CANCER
- Inflammation and cancer: What a surgical oncologist should know
- (2018) Aurélien Dupré et al. EJSO
- Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
- (2018) Jinyang Li et al. IMMUNITY
- Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
- (2018) Michail Ignatiadis et al. JNCI-Journal of the National Cancer Institute
- Immunotherapeutic interventions of Triple Negative Breast Cancer
- (2018) Zehuan Li et al. Journal of Translational Medicine
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
- (2018) Marco Bezzi et al. NATURE MEDICINE
- A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
- (2018) Zhixian Liu et al. Translational Oncology
- The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
- (2018) Claudio Vernieri et al. Scientific Reports
- Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
- (2018) Michail Ignatiadis et al. JNCI-Journal of the National Cancer Institute
- The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
- (2018) Joanna L. Sylman et al. Frontiers in Oncology
- Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
- (2018) Kevin B. Givechian et al. npj Genomic Medicine
- Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
- (2018) Kenichi Harano et al. PLoS One
- Classification of triple-negative breast cancers based on Immunogenomic profiling
- (2018) Yin He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer
- (2018) Javier Cuello-López et al. PLoS One
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer
- (2017) Bárbara Reis Wariss et al. MATURITAS
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer
- (2017) Elena Muraro et al. Frontiers in Immunology
- Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors
- (2017) Sandra Martínez-Canales et al. PLoS One
- Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer
- (2017) Hideya Takeuchi et al. PLoS One
- In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
- (2017) Joseph A. Pinto et al. Scientific Reports
- The genomic landscape of breast cancer and its interaction with host immunity
- (2016) Stephen Luen et al. BREAST
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma
- (2016) Jie Wang et al. OncoTargets and Therapy
- Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
- (2016) Chao Liu et al. OncoTargets and Therapy
- Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
- (2016) Yanyun Zhu et al. Oncotarget
- CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
- (2016) Federica Turdo et al. Oncotarget
- Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
- (2016) L. D. Miller et al. Cancer Immunology Research
- A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease
- (2016) Joseph A Pinto et al. npj Genomic Medicine
- Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk
- (2015) Yildiz Okuturlar et al. Asian Pacific Journal of Cancer Prevention
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
- (2015) I. Acerbi et al. Integrative Biology
- Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
- (2015) Natalie Turner et al. INTERNATIONAL JOURNAL OF CANCER
- Role of inflammatory infiltrates in triple negative breast cancer: Table 1
- (2015) Hirofumi Matsumoto et al. JOURNAL OF CLINICAL PATHOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy
- (2015) Qing Chen et al. TUMOR BIOLOGY
- Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis
- (2015) H Bonsang-Kitzis et al. OncoImmunology
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Cancer and systemic inflammation: treat the tumour and treat the host
- (2014) C S D Roxburgh et al. BRITISH JOURNAL OF CANCER
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) A. J. Templeton et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells
- (2014) Ilaria Plantamura et al. Molecular Oncology
- Prognostic Value of PLR in Various Cancers: A Meta-Analysis
- (2014) Xin Zhou et al. PLoS One
- The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
- (2014) Yan Mao et al. PLoS One
- Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
- (2014) B. Mlecnik et al. Science Translational Medicine
- Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
- (2014) Peifen Fu et al. OncoTargets and Therapy
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma
- (2013) Alipasha Rassouli et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer Patients
- (2013) Hany Noh et al. Journal of Breast Cancer
- Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer
- (2013) Deva Sharma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Understanding the biology of triple-negative breast cancer
- (2012) C. Criscitiello et al. ANNALS OF ONCOLOGY
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
- (2012) Supachai Raungkaewmanee et al. Journal of Gynecologic Oncology
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- A flexible R package for nonnegative matrix factorization
- (2010) Renaud Gaujoux et al. BMC BIOINFORMATICS
- Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors
- (2010) Sara Mariucci et al. CLINICAL AND EXPERIMENTAL MEDICINE
- The platelet contribution to cancer progression
- (2010) N. M. BAMBACE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Breast cancer special types: why bother?
- (2008) JS Reis-Filho et al. JOURNAL OF PATHOLOGY
- Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
- (2008) Sandra D Bohling et al. MODERN PATHOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started